RS20050835A - Sastavi bukalnih doznih oblika za produženo otpuštanje leka i postupak za njihovo dobijanje - Google Patents
Sastavi bukalnih doznih oblika za produženo otpuštanje leka i postupak za njihovo dobijanjeInfo
- Publication number
- RS20050835A RS20050835A YUP-2005/0835A YUP83505A RS20050835A RS 20050835 A RS20050835 A RS 20050835A YU P83505 A YUP83505 A YU P83505A RS 20050835 A RS20050835 A RS 20050835A
- Authority
- RS
- Serbia
- Prior art keywords
- composition according
- indion
- group
- release
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN26DE2004 | 2004-01-06 | ||
| IN24DE2004 | 2004-01-06 | ||
| PCT/IN2005/000003 WO2005065640A1 (fr) | 2004-01-06 | 2005-01-05 | Nouvelles compositions pour formes posologiques orales, et procede de preparation de telles compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS20050835A true RS20050835A (sr) | 2007-08-03 |
Family
ID=34751866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YUP-2005/0835A RS20050835A (sr) | 2004-01-06 | 2005-01-05 | Sastavi bukalnih doznih oblika za produženo otpuštanje leka i postupak za njihovo dobijanje |
Country Status (2)
| Country | Link |
|---|---|
| RS (1) | RS20050835A (fr) |
| WO (1) | WO2005065640A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007096906A2 (fr) * | 2006-02-27 | 2007-08-30 | Panacea Biotec Ltd. | Nouvelles compositions bucco-adhésives et procédé d'élaboration desdites compositions |
| CN100450548C (zh) * | 2006-12-22 | 2009-01-14 | 江苏奥赛康药业有限公司 | 一种波拉克林树脂组合物的口腔贴片及其制备方法 |
| WO2008155620A1 (fr) * | 2007-06-20 | 2008-12-24 | Develco Pharma Schweiz Ag | Forme posologique contenant une matrice dispersible de granulés à libération entretenue |
| US8133506B2 (en) | 2008-03-12 | 2012-03-13 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
| EP3108876A1 (fr) * | 2011-10-13 | 2016-12-28 | Jaleva Pharmaceuticals LLC | Procédés et compositions pour administration rapide d'agents actifs par la bouche |
| EP2906210A4 (fr) * | 2012-10-12 | 2016-06-08 | Jaleva Pharmaceuticals Llc | Procédé de préparation de teintures de résine |
| EP2925273A4 (fr) | 2012-11-28 | 2016-08-31 | Jaleva Pharmaceuticals Llc | Applicateur à deux chambres |
| CN105232502A (zh) * | 2015-02-10 | 2016-01-13 | 万全万特制药江苏有限公司 | 含波拉克林钾和盐酸氟西汀复合物的口崩片及其制备方法 |
| ES2983269T3 (es) * | 2015-07-23 | 2024-10-22 | Athena Pharmaceutiques Sas | Composición de zolpidem y proceso de preparación de la misma |
| CN114344241B (zh) * | 2021-12-15 | 2024-01-30 | 悦康药业集团安徽天然制药有限公司 | 一种聚丙烯酸树脂改性吸附药物载体及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1238072B (it) * | 1990-01-19 | 1993-07-03 | Sclavo Spa | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina |
| AU3455297A (en) * | 1996-07-11 | 1998-02-09 | Farmarc Nederland Bv | Pharmaceutical composition containing acid addition salt of basic drug |
| DE19932603A1 (de) * | 1999-07-13 | 2001-01-25 | Gruenenthal Gmbh | Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren |
| JP2004532838A (ja) * | 2001-03-02 | 2004-10-28 | ブリストル−マイヤーズ スクイブ カンパニー | メラノコルチン受容体のモデュレーターとして有用な化合物及びそれを含む製薬組成物 |
| US7276246B2 (en) * | 2003-05-09 | 2007-10-02 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
-
2005
- 2005-01-05 RS YUP-2005/0835A patent/RS20050835A/sr unknown
- 2005-01-05 WO PCT/IN2005/000003 patent/WO2005065640A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005065640A8 (fr) | 2005-12-08 |
| WO2005065640A1 (fr) | 2005-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5627455B2 (ja) | 速崩性錠剤製造のための医薬製剤 | |
| EP1555022B1 (fr) | Formulation d'acetaminophene et de tramadol a liberation prolongee | |
| US20050250838A1 (en) | Formulation for sustained delivery | |
| CN101534792A (zh) | 包含氧可酮的粒剂和口腔崩解片剂 | |
| JP2017206517A (ja) | 薬物置換療法のためのブプレノルフィンウェハー | |
| JP2011513391A (ja) | ミコフェノラートを含有する徐放性医薬組成物およびその方法 | |
| CN103002882B (zh) | 不含活性剂之颗粒及包含其之片剂的制备 | |
| JP2001172201A (ja) | 経口投与形のための味をマスキングするコーティングとしてのフィルム被覆の使用、経口投与形及びその製造法 | |
| CN103002881B (zh) | 载有活性剂的颗粒与额外活性剂的组合 | |
| JP2010529073A (ja) | チュアブル錠及びトローチ剤製造のための医薬製剤 | |
| JPH05201866A (ja) | 配合製剤 | |
| EP2405900A2 (fr) | Nouvelle composition à libération prolongée de composés choisis dans la classe des relaxants musculaires à action centrale | |
| JP2016188181A (ja) | ミラベグロン含有放出制御錠剤 | |
| KR102479497B1 (ko) | 바레니클린 서방성 제제 및 이의 제조 방법 | |
| JP3239319B2 (ja) | 医薬投与形態の製造法 | |
| CN114929207A (zh) | 利奥西呱的调节释放型药物组合物 | |
| KR20090122344A (ko) | 실로스타졸을 함유하는 제어방출 제제 및 이의 제조방법 | |
| RS20050835A (sr) | Sastavi bukalnih doznih oblika za produženo otpuštanje leka i postupak za njihovo dobijanje | |
| CN112449601B (zh) | 含纳呋拉啡口腔崩解片 | |
| CN102307575B (zh) | 含醋氯芬酸的控释口服药制剂及其制造方法 | |
| JP2007520547A (ja) | ベンラファキシン塩酸塩の徐放性コーティングされた小型錠剤 | |
| JP2009501785A (ja) | 新規な調節放出性医薬製剤シクロオキシゲナーゼ酵素阻害剤 | |
| JP2018065776A (ja) | 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法 | |
| EP1512394B1 (fr) | Composition universelle à libération controlée comprenant du chitosane | |
| CN1720026A (zh) | 含有阿夫唑嗪的缓释组合物 |